{
  "company": {
    "name": "Hedera Dx",
    "website": "https://hederadx.com/",
    "record": "https://startuphistory.org/c/hederadx.com"
  },
  "status": null,
  "history_since": "2021-12-20T05:11:40.000Z",
  "baseline": {
    "snapshot_id": "81b56bf3a90b4c329220b68a0e9c01c5f1dff34c7fd257c96fccb5ac8ecec3d1",
    "observed_at": "2021-12-20T05:11:40.000Z",
    "headline": "The future of cancer detection is now",
    "description": "Hedera Dx: Getting everybody tested for cancer when it matters most.",
    "evidence": "https://web.archive.org/web/20211220051140/https://www.hederadx.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:17:31.700Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2021-12-20T05:11:40.000Z",
      "variants": [
        {
          "headline": "The future of cancer detection is now",
          "subhead": "Hedera Dx: Getting everybody tested for cancer when it matters most.",
          "observed_at": "2021-12-20T05:11:40.000Z",
          "evidence": "https://web.archive.org/web/20211220051140/https://www.hederadx.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "The future of cancer detection is now",
      "subhead": "Hedera Dx: Getting everybody tested for cancer when it matters most.",
      "from": "2021-12-20T05:11:40.000Z",
      "to": "2021-12-20T05:11:40.000Z",
      "captures": 1,
      "evidence": "https://web.archive.org/web/20211220051140/https://www.hederadx.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "on": "2021-12-20T05:11:40.000Z"
      },
      "current": false
    },
    {
      "quote_observed_at": "2025-07-10T22:53:52.000Z",
      "variants": [
        {
          "headline": "Liquid biopsies will provide better therapy options for more patients",
          "subhead": "Hedera Dx’s liquid biopsy solution radically streamlines tumor profiling, enabling hospital labs to run compliant and clinically actionable liquid biopsies in-house.",
          "observed_at": "2022-09-21T07:27:44.000Z",
          "evidence": "https://web.archive.org/web/20220921072744/https://www.hederadx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Liquid biopsies provide more therapy options for more patients",
          "subhead": "Hedera Dx’s liquid biopsy solution radically streamlines tumor profiling, enabling hospital labs to run compliant and clinically actionable liquid biopsies in-house.",
          "observed_at": "2023-02-21T06:26:24.000Z",
          "evidence": "https://web.archive.org/web/20230221062624/https://www.hederadx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Liquid biopsies provide more therapy options for more patients",
          "subhead": "Hedera Dx’s liquid biopsy solution radically streamlines tumor profiling, enabling hospital labs to run compliant and clinically actionable liquid biopsies in-house.",
          "observed_at": "2023-09-25T22:31:59.000Z",
          "evidence": "https://web.archive.org/web/20230925223159/https://www.hederadx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Liquid biopsies provide better therapy options for more patients",
          "subhead": "Hedera Dx’s liquid biopsy solution radically streamlines tumor profiling, enabling hospital labs to run compliant and clinically actionable liquid biopsies in-house.",
          "observed_at": "2024-02-14T18:31:33.000Z",
          "evidence": "https://web.archive.org/web/20240214183133/https://www.hederadx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Liquid biopsies provide better therapy options for more patients",
          "subhead": "Hedera Dx’s liquid biopsy solution radically streamlines tumor profiling, enabling hospital labs to run compliant and clinically actionable liquid biopsies in-house.",
          "observed_at": "2024-07-05T03:22:51.000Z",
          "evidence": "https://web.archive.org/web/20240705032251/https://www.hederadx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Liquid biopsies provide better therapy options for more patients",
          "subhead": "Hedera Dx’s liquid biopsy solution radically streamlines tumor profiling, enabling hospital labs to run compliant and clinically actionable liquid biopsies in-house.",
          "observed_at": "2025-01-20T14:59:40.000Z",
          "evidence": "https://web.archive.org/web/20250120145940/https://www.hederadx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Liquid biopsies provide better therapy options for more patients",
          "subhead": "Hedera Dx’s liquid biopsy solution radically streamlines tumor profiling, enabling hospital labs to run compliant and clinically actionable liquid biopsies in-house.",
          "observed_at": "2025-07-10T22:53:52.000Z",
          "evidence": "https://web.archive.org/web/20250710225352/https://www.hederadx.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Liquid biopsies provide better therapy options for more patients",
      "subhead": "Hedera Dx’s liquid biopsy solution radically streamlines tumor profiling, enabling hospital labs to run compliant and clinically actionable liquid biopsies in-house.",
      "from": "2022-09-21T07:27:44.000Z",
      "to": "2025-07-10T22:53:52.000Z",
      "captures": 7,
      "evidence": "https://web.archive.org/web/20250710225352/https://www.hederadx.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2022-09-21T07:27:44.000Z",
          "to": "2025-07-10T22:53:52.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:17:31.700Z",
      "variants": [
        {
          "headline": "Modern cancer care for the next billion people",
          "subhead": "Hedera Dx enables health systems, patients and drug discovery programs to easily adopt advanced molecular testing and real-world evidence (RWE) capabilities.",
          "observed_at": "2026-05-19T09:25:24.000Z",
          "evidence": "https://web.archive.org/web/20260519092524/https://www.hederadx.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Modern cancer care for the next billion people",
          "subhead": "Hedera Dx enables health systems, patients and drug discovery programs to easily adopt advanced molecular testing and real-world evidence (RWE) capabilities.",
          "observed_at": "2026-11-06T17:17:31.700Z",
          "evidence": "https://www.hederadx.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Modern cancer care for the next billion people",
      "subhead": "Hedera Dx enables health systems, patients and drug discovery programs to easily adopt advanced molecular testing and real-world evidence (RWE) capabilities.",
      "from": "2026-05-19T09:25:24.000Z",
      "to": "2026-11-06T17:17:31.700Z",
      "captures": 2,
      "evidence": "https://www.hederadx.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-05-19T09:25:24.000Z",
          "to": "2026-11-06T17:17:31.700Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "classifier-81b56bf3a90b4c329220b68a0e9c01c5f1dff34c7fd257c96fccb5ac8ecec3d1:34ce2e4a14ce9a70473d13a6189a165f43e95b7c348378e425c8ca29f2d8b9eb:repositioning",
      "before_evidence": "https://web.archive.org/web/20211220051140/https://www.hederadx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "repositioning",
      "label": "Messaging",
      "summary": "Changed its homepage headline from “The future of cancer detection is now” to “Liquid biopsies will provide better therapy options for more patients”. A classifier read this as a change in its core product.",
      "between": {
        "from": "2021-12-20T05:11:40.000Z",
        "to": "2022-09-21T07:27:44.000Z"
      },
      "evidence": "https://web.archive.org/web/20220921072744/https://www.hederadx.com/",
      "evidence_kind": "internet_archive",
      "basis": "classifier",
      "topic": "https://startuphistory.org/t/repositioned"
    },
    {
      "n": 2,
      "id": "classifier-2dc9bfa8456160ddb91f20c977dfd70a32f0b6ebf78d1d48684310b1f83c930c:657a724fa3b103ff7cf5087d9c2c49df122d816eb7edefd824d85c583986a028:repositioning",
      "before_evidence": "https://web.archive.org/web/20250710225352/https://www.hederadx.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "repositioning",
      "label": "Messaging",
      "summary": "Changed its homepage headline from “Liquid biopsies provide better therapy options for more patients” to “Modern cancer care for the next billion people”.",
      "between": {
        "from": "2025-07-10T22:53:52.000Z",
        "to": "2026-05-19T09:25:24.000Z"
      },
      "evidence": "https://web.archive.org/web/20260519092524/https://www.hederadx.com/",
      "evidence_kind": "internet_archive",
      "basis": "classifier",
      "topic": "https://startuphistory.org/t/repositioned"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Hedera Dx” company record, https://startuphistory.org/c/hederadx.com"
}